Yutaka Kawakami - Concepedia

Author

Yutaka Kawakami

Also Known As

Kawakami Y., Kawakami, Yutaka, Y KAWAKAMI, Y Kawakami, Y. Kawakami, Y., Kawakami, YUTAKA KAWAKAMI, Yutaka KAWAKAMI, Yutaka Kawakami, yutaka Kawakami

457

Publications

21.8K

Citations

H-Index

182

Concepts

All Affiliations

Keio University Institute for Advanced Medical Research National Institutes of Health National Cancer Institute The University of Tokyo

About

Yutaka Kawakami is an author at Keio University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	95	11.8K
2	Health Sciences	4	4	143
3	Engineering	2	2	96
4	Natural Sciences	2	2	145
5	Public Health	2	2	71

Yutaka Kawakami

207

Publications

18.8K

Citations

H-Index

Page 1

	Year	Citations
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Yutaka Kawakami, S Eliyahu, C H Delgado, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyPathologyAntigen ProcessingImmunotherapy	1994	1.1K
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity Takeshi Tanoue, Satoru Morita, Damian R. Plichta, Nature Cancer ImmunosurveillanceAutoimmune DiseaseCd8 T CellsT-regulatory CellImmunology	2019	1.1K
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Yutaka Kawakami, S Eliyahu, C H Delgado, Proceedings of the National Academy of Sciences ImmunologyPathologyImmunophenotypingAntigen ProcessingImmunotherapy	1994	926
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells Hidetoshi Sumimoto, Fumie Imabayashi, Tomoko Iwata, The Journal of Experimental Medicine Stat3 SignalImmunologyImmunoeditingImmunotherapyCancer Biology	2006	704
Identification of human cancers deficient in antigen processing. Nicholas P. Restifo, Yutaka Kawakami, Jonathan W. Yewdell, The Journal of Experimental Medicine Tumor BiologyCancer ImmunosurveillanceMhc-encoded ProteasomeMhc ClassImmunology	1993	626
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. Alexander B. H. Bakker, Marco W.J. Schreurs, Annemiek J. de Boer, The Journal of Experimental Medicine Gp100 CdnaImmunologyPathologyAntigen ProcessingImmunotherapy	1994	579
Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues Maria R. Parkhurst, Michael L. Salgaller, Scott Southwood, The Journal of Immunology	1996	559
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. Paul F. Robbins, Mona El‐Gamil, Yongfeng Li, The Journal of Experimental Medicine ImmunologyPathologyAntigen ProcessingBeta-catenin GeneImmunotherapy	1996	547
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. Yutaka Kawakami, S Eliyahu, Cheryl Jennings, The Journal of Immunology ImmunologyPathologyAntigen ProcessingImmunotherapyVivo Tumor Regression	1995	541
Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation Masataka Kuwana, Yuka Okazaki, Hiroaki Kodama, Journal of Leukocyte Biology	2003	301

Page 1